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Background: Currently, men are younger at the time of diagnosis of prostate cancer and more interested in less
invasive surgical approaches (traditional laparoscopy, 3D-laparoscopy, robotics). Outcomes of continence, erectile
function, cancer cure, positive surgical margins and complication are well collected in the pentafecta rate. However,
no comparative studies between 4th generation 3D-HD vision system laparoscopy and standard bi-dimensional
laparoscopy have been reported. This study aimed to compare the operative, perioperative data and pentafecta rates
between 2D and 3D laparoscopic radical prostatectomy (LRP) and to identify the actual role of 3D LRP in urology.
Methods: From October 2012 to July 2013, 86 patients with clinically localized prostate cancer [PCa: age≤ 70 years,
prostate-specific antigen (PSA)≤ 10 ng/ml, biopsy Gleason score≤ 7] underwent laparoscopic extraperitoneal radical
prostatectomy (LERP) and were followed for approximately 14 months (range 12–25). Patients were selected for inclusion
via hospital record data, and divided into two groups. Their patient records were then analyzed. Patients were randomized
into two groups: the former 2D-LERP (43 pts) operated with the use of 2D-HD camera; the latter 3D-LERP (43 pts)
operated with the use of a 3D-HD 4th generation view system. The operative and perioperative data and the pentafecta
rates between 2D-LERP and 3D-LERP were compared.
Results: The overall pentafecta rates at 3 months were 47.4% and 49.6% in the 2D- and 3D-LERP group respectively.
The pentafecta rate at 12 months was 62.7% and 67% for each group respectively. 4th generation 3D-HD vision system
provides advantages over standard bi-dimensional view with regard to intraoperative steps. Our data suggest a trend
of improvement in intraoperative blood loss and postoperative recovery of continence with the respect of the oncological
safety.
Conclusions: Use of the 3D technology by a single surgeon significantly enhances the possibility of achieving better
intraoperative results and pentafecta in all patients undergoing LERP. Potency was the most difficult outcome to reach
after surgery, and it was the main factor leading to pentafecta failure. Nevertheless, further studies are necessary to better
comprehend the role of 3D-LERP in modern urology.
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Prostate cancer is the most common tumor in people
aged over 50 and is the second leading cause of cancer
death in Europe and in the United States. Worldwide,
nearly 900,000 men were estimated to have been diag-
nosed with prostate cancer during 2008 and 258,000
men died for this reason [1]. Incidence in Western coun-
tries is higher than in less developed ones where it is
slowly increasing. Furthermore, there were recent sig-
nificant decreases in prostate cancer mortality in Europe
and in the United States. In contrast, mortality rates
have increased in other countries [2,3]. Decreasing mor-
tality rates is mainly due to earlier diagnosis and im-
proved treatment.
Laparoscopic radical prostatectomy (LRP) has become
an established treatment for organ confined prostate
cancer and is increasingly performed at selected centers
worldwide even though open radical retropubic prosta-
tectomy (RRP) is widely considered the treatment of
choice. For the first time in 1992 Schuessler carried out
a LRP in order to transfer the well-known advantages of
the laparoscopic technique to the most common open
surgical treatment for prostate cancer [4]. Only after
years, Guillonneau and Valencien improved the tech-
niques obtaining results similar to those of open surgery
but, because of the steep learning curve, laparoscopic
radical prostatectomy has slowly risen in popularity [5].
The advent of robotic surgery has further helped to con-
fine laparoscopic surgery to a special niche. Shorter
learning curve, three-dimensional view as well as the
ease of movement offered by the Da Vinci® operating
arms have made robot-assisted laparoscopic prostatec-
tomy (RALP) more reproducible despite the higher
costs. So RALP is easier to learn and is now the surgical
treatment of choice in most centers of excellence in the
United States [6].
Nowadays, laparoscopic surgery could be regenerated by
the introduction of a high-resolution three-dimensional
view (3D). 3D techniques have been improved in compari-
son to the first generation of 3D vision system introduced
in the 90s and can even replace the classic bi-dimensional
view [7]. 3rd-generation three-dimensional view was intro-
duced about 10 years ago but few experiences were re-
ported in literature probably due to some limit of this
technique. The use of a quite heavy helmet with a head
mounted display caused surgeon fatigue [8,9]. 4th-
generation three-dimensional system uses more ergo-
nomic glasses and an innovated technology.
Better knowledge of pelvic anatomy, improvements in
surgical technique have led to improved oncological results
and reduced adverse functional outcomes. Historically,
outcomes of continence, erectile function, and oncologic
control were the major surgical achievement and were
called ‘trifecta’ outcomes. Nowadays, patients with adiagnosis of prostate cancer are younger, healthier and
have higher expectations from the advanced minimally in-
vasive surgical technologies. Hence, the ‘pentafecta’ was
proposed as a new method of outcomes analysis by adding
early complications and positive surgical margins (PSMs) to
trifecta [10]. According to these theories, pentafecta has be-
come a new cornerstone in the analysis of urological sur-
gery results.
In this pilot randomized study, we aim to highlight the
differences between the standard two-dimensional (2D)
with the 4th-generation three-dimensional view (3D) ap-
plied to laparoscopic extraperitoneal radical prostatec-
tomy (LERP) in order to assess if the 3D visualization of
the operative field could really improve intraoperative
and perioperative steps and the pentafecta outcomes.
Methods
Patients and technologies
From October 2012 to July 2013, all patients with clin-
ical T1c prostate tumor, belonging to low/intermediate
D’Amico risk group, were included in the study. 86 con-
secutive patients, who met these criteria, underwent
LERP. Patients were selected for inclusion via hospital
record data. The data were collected in a database and
retrospectively analyzed. Fondazione PTV – Policlinico
Tor Vergata Ethic Committee approved our clinical
study and data collection. In accordance with our insti-
tution’s Ethic Committee, informed and signed consent
was obtained from each patient prior treatment. A state-
ment of ethical approval covered permission to access
patient records and use them for study purposes. All pa-
tients constituting the cohort had at least 1 yr follow-up.
Patients were randomized into two groups: the former
2D-LERP (43 pts) operated with the use of 2D-HD Storz®
camera with a 10 mm 0° laparoscope; the latter 3D-LERP
(43 pts) operated with the use of a 3D-HD Viking® camera
with a 10 mm and 0° lens double-channel stereo-
laparoscope. The 3D view is achieved with the help of a
3DHD Viking® screen and with the use of polarized
glasses. The glasses are filtered; each lens only lets one
direction of light pass through the eye, thus maintain-
ing two perspectives of the image and giving a tridi-
mensional vision.
Procedures: surgery and rehabilitation
All 86 patients were operated by the same surgeon (P.B.)
following the same surgical technique of LERP. A 1,5 cm
cutaneous incision is made at 1 cm below the inferior
margin of the umbilicus and a dilator device is inserted
into the preperitoneal space and about 300 ml of air is
inflated to develop the space of Retzius (pneumo-
Retzius). 4 secondary trocars are then placed under lap-
aroscopic view (2 for each iliac fossa, right and left) in
the inverted fan configuration. The endopelvic fascia is
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isolated through the “bladder neck sparing” technique.
Once the bladder neck is opened close to the prostate,
the posterior lip of the bladder neck is lowered to pro-
vide access to the interprostatorectal plane. Vasa
deferentes and seminal vesicles are isolated and dis-
sected. Then, prostatic pedicles are incised in an
anterograde mode with preservation of the neurovas-
cular bundle when it is indicated. Finally, a meticulous
preparation of the urethral stump introduces to the
vesicourethral anastomosis which is collected in inter-
rupted sutures [11].
The drainage is left in place until leakage is observed,
and normally it is removed on second post-operative
day. Urinary fistula is defined as prolonged drainage over
postoperative day 10. The catheter is normally removed
between 7 and 10 days after surgery; in case of urinary
fistula a cystography is carried out on 14th and 21st
postoperative day and both drainage and catheter are re-
moved at the complete closure of the anastomosis.
Baseline sexual and urinary functions were assessed
before LERP with self-administered, validated question-
naires: the International Index of Erectile Function 6
(IIEF-6) and the Incontinence Quality of Life (I-QoL)
[12,13].
Pelvic floor muscles exercises were recommended for
all patients immediately after catheter removal in order
to facilitate continence recovery. After catheter removal,
all patients received phosphodiesterase type 5 (PDE5) in-
hibitors at least three times a week and began penile re-
habilitation no later than three weeks after radical
surgery by using intracavernous pharmacotherapy (ICP)
with Prostaglandin E1 (alprostadil).Table 1 Preoperative data
Variable 2D 3D
Age, yr, mean 60.1 63.9




Biopsy Gleason score 6.15 6.15Data collection
Operative and perioperative data. Operative time
(OT – from skin to skin closure), anastomosis time
(AT – time to complete the anastomosis till the cath-
eter insertion), number of stitches used (NuS), esti-
mated blood loss (EBL) and any intraoperative
complication were recorded. Perioperative data in-
clude: days of drainage (DD), days of catheterization
(DC), hospital stay (HS), pathological staging and com-
plications. Histopathologic staging was performed ac-
cording to the 2002 TNM system [14].
Pentafecta. The five outcomes included in the ana-
lysis of the pentafecta are complications, positive sur-
gical margins (PSMs) and the trifecta outcomes
(urinary continence, sexual potency, biochemical re-
currence BCR-free survival rates). Pentafecta is
achieved if there were no complications, negative sur-
gical margins and if the patient was continent, potent
and BCR-free.Statistical analysis
Fisher test was used to analyze non-parametric data as
appropriate. Student t-test was used to analyze paramet-
ric data such as patients’ characteristics, intra and
remaining perioperative data. Results were considered
significant if the p value was ≤ 0.05.
Results
There were not significant differences between the two
groups in terms of age, body mass index (BMI), pre-
operative PSA level and biopsy Gleason score. Patients’
characteristics are summarized in Table 1.
Operative and perioperative data
Operative and perioperative data are presented in
Table 2. Median OT for 3D-LERP was significantly
shorter than that in 2D-LERP (162 versus 241 minutes,
p 0.01). Moreover, in the 3D LERP group, median OT
for the first 3 cases was significantly longer than the
remaining cases due to the initial operator learning
curve. Statistically significant differences were also re-
corded in median AT (24 versus 32 minutes, p 0.03) and
median NuS (5.65 versus 6.45, p 0.018). Median EBL did
not reach a statistical significance in the two groups with
two patients requiring transfusion in the 2D group and 1
patient in the 3D group. No conversion to open surgery
was necessary and no complications occurred requiring
early re-intervention. Median HS was 7.6 and 5.5 days
for the 2D-LERP and 3D-LERP respectively (p = 0.180).
Median DD was 5 in the 2D-LERP and 4,5 in the 3D-
LERP (p = 0.925). The median CT was of 10.55 days and
10.75 days for the 2D to 3D respectively (p = 0.880).
Complications
Complications can be considered as a perioperative out-
come. We discussed complications apart from the other
perioperative data in order to underline their role in the
pentafecta.
Modified Clavien grading system was used to classify
complications occurring during the surgical procedure or
within 90 days after surgery (early complications) [15].
Twenty-three of 86 patients experienced complications.
More specifically, perioperative complications were re-
ported in 15 (34.8%) cases in the 2D-LRP and in 8 (18.6%)
cases in the 3D-LRP. 2D-LRP and 3D-LRP complications
Table 2 Intraoperative and perioperative data
Intraoperative data




















Days of drainage 4.5 4.85 0.92
Days of catheterization 10.55 10.75 0.88
Hospital stay 7.6 5.5 0.18
*Statistically significant differences.
Table 4 Histopathologic data
2-D 3-D
(n = 43) (n = 43)
Pathologic stage
pT2a 5 (12%) 6 (14%)
pT2b 3 (7%) 3 (7%)
pT2c 25 (58%) 23 (54%)
pT3a 7 (16%) 8 (18%)
pT3b 3 (7%) 3 (7%)
Specimen
Gleason score
6 (3 + 3) 23 (53%) 23 (53%)
7 (3 + 4) 8 (18%) 9 (21%)
7 (4 + 3) 11 (26%) 9 (21%)
8 (4 + 4) 1 (2%) 2 (5%)
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grade 1 and 2) represent respectively 80% and 63% for the
two groups of all those reported. Major complications
(Clavien grade ≥ 3) constituted respectively 20% and 37%.
There were no cases of complications graded 4a, 4b and 5
according to the modified Clavien grading system. Data
are depicted in Table 3.
Oncologic outcomes: biochemical recurrence and positive
surgical margins
Oncological results are presented in Tables 4 and 5. The
distribution of pathological stage and Gleason score was




(n = 43) (n = 43)




(n = 7) (n = 5)
Hematuria (n = 1) 0
bladder catheter
exchange (n = 1)
0
Grade 2 transfusions (n = 2) 0
Epididymitis (n = 1)
Grade 3a AUR (n = 1) AUR (n = 1)
Anastomotic
stenosis (n = 2)
Anastomotic
stenosis (n = 1)
Grade 3b 0 Urinary fistula
(n = 1)
Grade 4a-b/5 0 0
Total (%) 34.8% (15) 18.6% (8)
Minor 80% Minor 63%
Major 20% Major 37%The overall PSM rate was 9% in the 2D-LERP and 4%
in the 3D-LERP. When stratified by pathological stage,
PSM rate was significantly different in pT2c/pT3 disease
between groups (halved in the 3D-LERP compared with
the 2D-LRP group).
BCR was defined as two consecutive prostate-specific
antigen (PSA) levels of >0.2 ng/ml [16]. The overall
BCR-free rate at 3 months was 93% (2D-LERP, 40 pa-
tients) and 95% (3D-LERP, 41 patients). Reassessed at
12 months, the overall BCR-free rate was 88% (2D-LERP,
38 patients) and 91% (3D-LERP, 39 patients). Patients
with recurrences underwent further salvage therapy with
either radiation and/or hormonal treatment. Aligned
with the literature data, 25% of the patients with BCR
had PSMs.Urinary continence
According to the European Association of Urology
Guidelines (EAU Guidelines, 2013), urinary incontinence
represents a postoperative complication that persists
after 1 year in 7.7% of patients who underwent radical
prostatectomy [17]. The American Urological Association
Guidelines (AUA Guidelines, 2007 updated in 2011)Table 5 Oncological results
2-D 3-D
(n = 43) (n = 43)




3 months follow-up 93% (40) 95% (41)
12 months follow-up 88% (38) 91% (39)
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ranges between 3% and 74% [18].
Urinary continence was assessed with the self-
administered, validated questionnaire Incontinence
Quality of Life (I-QoL). The definition of continence
was based on a specific question appropriate to reflect
the range of incontinence severity: “How many pads per
day did you usually use to control urine leakage during
the last 4 weeks?”. We considered “dry” patients without
any loss of urine (no pads/day) or those who used a safety
pad/day.
The overall continence rates did not reach a statisti-
cally significant difference although the trend is clearly
favorable to the 3D-LERP group (89% and 92% vs 83%
and 88% of patients were continent at 3 and 12 month
follow-up in the 3D and 2D-LERP group respectively).
I-QoL questionnaire showed a significant quality of life
improvement at the first month in the 3D (mean score
90,45) compared to the 2D-LERP group (mean score
81,8) (p = 0.01). These positive results are also confirmed
at third (93.3 vs 83.6 - p = 0.01) and twelfth (95.4 vs 88.1
p = 0.03) month follow-up in the 3D compared to the
2D-LERP group respectively. Pre- and postoperative
urinary continence data are depicted in Table 6.
Erectile function
It is widely recognized that the preoperative Erectile
Function (EF) is an important prognostic factor for
erectile dysfunction recovery after radical prostatectomy
[19]. Several other factors are predictive for EF recovery
after surgery: age, type of surgery, pre- and post-RP li-
bido, adjuvant treatments, comorbidities, urinary contin-
ence, availability of a partner and sane mental health.
Therefore, it is essential to determine the EF baseline.
The International Consultation on Sexual Medicine
(ICSM) Committee recommends the use of validated
psychometric instruments such as IIEF. In our experi-
ence, potency rate has been assessed using the IIEF-6.
After surgery, erectile function rehabilitation was recom-
mended for all patients (scheme reported above) in
order to preserve the functional smooth muscle tissue ofTable 6 Continence data
Pad system 2-D 3-D
n = 43 n = 43
Pre-operative 100% (43) 100% (43)
3 months follow-up 83% (36) 89% (38)
12 months follow-up 88% (38) 92% (40)
IQoL 2-D 3-D
n = 43 n = 43
3 months follow-up 83,6 93,3
12 months follow-up 88,1 95,4the corpora cavernosa and to avoid the effects of the
surgical-related neuroapraxia [20].
Preoperative Potency was defined as the ability to
achieve and maintain satisfactory erection for sexual ac-
tivity or as a score IIEF-6 score ≥ 17 (without pharmaco-
logical or mechanical support). Post-operative potency
was defined as the ability to achieve and maintain erec-
tions firm enough for sexual intercourse in more than
50% of attempts, with or without the use of iPDE5 and
with eventual ICP (IIEF-6 score ≥ 17).
Patients were subjected to bilateral or unilateral nerve-
sparing surgery (NSS). The overall potency rates were 60%
and 67% at 3 months and 67% and 72% at 12 months in
the 2D- and 3D-LERP group respectively. Type of surgery,
pre-surgical evaluation of erectile function and potency
outcomes are summarized in Tables 7 and 8.
Pentafecta outcomes
The overall pentafecta rate at 3 months was 47.4% and
49.6% in the 2D- and 3D-LERP group respectively. The
pentafecta rate at 12 months was 62.7% and 67% for
each group respectively.
The most common reasons for not achieving the pen-
tafecta were erectile dysfunction (33% and 28% respect-
ively in 2D-LERP and 3D-LERP; trifecta not achieved)
and complication rate (34.8% and 18.6%, 2D vs 3D). Fur-
thermore, urinary incontinence (12% and 8%, 2D vs 3D),
BCR (12% and 9%, 2D vs 3D) and positive surgical mar-
gins (9% and 4%, 2D vs 3D). Results are shown in
Table 9.
Discussion
In the past decade, a dramatic shift towards lower-stage
tumors has become evident. Currently, men are younger
at the time of diagnosis and more interested in less inva-
sive surgical approaches (eg. Laparoscopy, robotics) than
they are for the traditional approach [21]. At the same
time and more importantly, normal continence and pre-
serving sexual function are fundamental but not the only
primary goals of radical prostatectomy. Patients want to
know if the treatment option will render them cancer
free with a minimum of complications and the shortest
possible convalescence time while preserving continence
and potency [10].
These observations highlight two main topics: on one
hand, the possibility of considering a minimally invasive sur-




Monolateral 42% (18) 37% (16)
Bilateral 58% (25) 63% (27)
Table 8 Potency data
Erectile Function IIEF 6 ≥ 17 2-D 3-D
n = 43 n = 43
Pre-operatory 86% (37) 88% (38)
3 months follow-up 60% (26) 67% (29)
12 months follow-up 67% (29) 72% (31)
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cessity of adopting a more comprehensive method of report-
ing peri- and post-operative outcomes.
By adopting the laparoscopic technique with adher-
ence to established oncological principles, the aim is to
duplicate the open surgical method in its entirety. LRP
has slowly risen in popularity and has become, in some
centers, the surgical approach of choice for the treat-
ment of localized prostate cancer for its advantages.
Lower blood loss and transfusion rate associated with
the laparoscopic approach together with shorter hospital
stay, reduced catheterization time, better pain control
and faster return to everyday activities seem to be the
most encouraging improvements obtained [22].
Unfortunately, classic laparoscopic surgery is limited
by a two-dimensional vision that does not allow percep-
tion of the operative field as in open surgery. The lack of
depth perception has repercussions both on the learning
curve, which still constitutes a major obstacle to the de-
velopment of laparoscopy [23], and in the possibility for
the surgeon to maneuver the instruments with an accur-
acy comparable to that which would occur in the same
“open” operation. Even if the experienced surgeon is able
over time to regain some vision of depth, this will never
be optimal [24].
For this reason and through the increasing popularity of
laparoscopy, a three-dimensional display system was intro-
duced in the early 90s, with the expectation that this tech-
nique could make laparoscopic interventions safer and
faster23. Up to now, just a few studies on three-dimensional
laparoscopy have been written without any definite conclu-
sion about its utility. Some articles describe better results
with 3D laparoscopic technique than with the 2D systemTable 9 Variables comprising the pentafecta success rates
at 12 mo
Variable 2D LERP 3D LERP
Patients % Patients %
Complication 28/43 65 35/43 81
PSM 39/43 91 41/43 96
BCR-free rate 38/43 88 39/43 91
Continence 38/43 88 40/43 92
Potency 29/43 67 31/43 72
Pentafecta 27/43 62,7 29/43 67both in surgical training exercises and in different surgical
procedures. Exercises like linear cutting and suturing,
curved cutting and suturing, tubular suturing and dorsal
vein complex suturing simulation have been performed
and it has been suggested that the new-generation 3D sys-
tem could be helpful in laparoscopy [25-27].
In the 90s, comparative studies were organized to
evaluate the improvement and superiority of vision be-
tween traditional 2D and 3D system (3rd generation) in
terms of dissection of the kidney, securing of the renal
vessels and laparoscopic suturing, but the Authors found
no differences between the two vision systems, either
with respect to the accuracy and speed of surgical exe-
cution, nor as regards to the learning curve [28-32].
Gynecologists and general surgeons have described
similar studies in the field of 3D laparoscopic surgery
with discordant conclusions [33-35].
Robotic surgery had a great benefit from the three-
dimensional view. The advent of Da Vinci® has further
helped to confine laparoscopic prostatectomy to a special
niche. Shorter learning curve, three-dimensional view as
well as the ease of movement offered by the operating
arms, makes robot-assisted laparoscopic prostatectomy
(RALP) more reproducible despite the higher costs. This
way, Robertson et al. recently underlined that RALP is
easier to learn and is now the surgical treatment of choice
in most centers of excellence in the United States [22].
This is the first study reported in urologic literature
that aims to establish, after twenty years since the first
3D model was introduced, the utility of the 4th gener-
ation 3D vision system during LERP in terms of feasibil-
ity and potential advantages over the 2D vision system
regarding operative and perioperative data and the pen-
tafecta outcomes. Only one work reported by Good
et al. in 2013 analyzed the pentafecta learning curve for
laparoscopic radical prostatectomy [36].
Transition from the 2D to 3D vision system, requires
an initial period of adaptation. This is demonstrated by
longer operative time and the incidence of post-
operative urinary fistula that occurred at the very be-
ginning of our experience using the 3D vision system.
This short learning curve is related to a new perception
of the depth of the operative field that requires a differ-
ent spatial assessment of instrument positioning rather
than an initial difficulty in recognizing anatomical land-
marks avoiding possible complications. Once adaptation
to 3D view is reached, a more realistic visualization of
the surgical field allows greater speed and precision in
the movement of the surgical instrument. This trans-
lates in a better preparation of the bladder neck and the
urethral stamp reducing anastomosis time. Although
not resulting in a statistically significant difference, the
easy identification of small vessels using the 3D vision
may reduce blood loss.
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sion by an expert laparoscopist, on the other hand, the
3D vision may offer significant advantages in teaching
laparoscopic skills to inexperienced individuals [37].
Meticulous handling and tissue dissection obtained
with the auxilium of the 3D view have allowed earlier
continence recovery. This could be mainly related to less
trauma and greater sphincter- structures saving [38] as
demonstrated by a better I-QoL and a decreased number
of pads per day in the 3D LERP Group. One of the oper-
ating steps that gets more advantages from the 3D view
is the dissection of seminal vesicles, vas deferens and
prostatic pedicles. Dissection of these delicate structures
makes 3D vision very effective. Basically, these operating
stages and their higher accuracy might affect a possible
earlier and better recovery of erectile function.
These encouraging results obtained with the 3D vision
system were associated with a number of positive surgi-
cal margins and post-operative complications compar-
able in both groups demonstrating a good oncological
and functional efficacy. From our point of view, some
problems related to the prolonged use of 3D vision such
as headaches, fatigue and nausea, already reported in
previous studies, have still remained unresolved, but it is
not an important limitation to its use [39,40].
Statistically significant differences were recorded for
all intraoperative steps and data suggest a trend of im-
provement in intraoperative blood loss, postoperative re-
covery of continence and potency with the respect of the
oncological safety for the 4th generation 3D-HD vision
system of the 3D-LERP over standard bi-dimensional
view in 2D-LERP.
One of the advantages of this study is that the com-
parison between the 2D and 3D surgical procedures was
performed by a single surgeon making it more reliable
and avoiding possible bias. Despite this fact, the exten-
sive experience of the surgeon may have influenced the
results and complication rates of our study and, as a re-
sult, the outcomes cannot be generalized.
However, this study has several limitations. First of all,
being a pilot study, with a small number of procedures
and a relatively short follow-up, it does not allow the
definition of the definitive role of this technique. Data
analysis was a retrospective. Some data may not reach a
statistical significance between groups because the study
was not powered to identify these differences; neverthe-
less, a trend of improvement in surgical and functional
outcomes has been shown. Furthermore, we included
both bilateral and monolateral NSS procedures. Another
limitation is that we did not use the Expanded Prostate
Cancer Index Composite (EPIC) questionnaire to better
assess urinary symptoms. Finally, the study is limited by
the short follow-up, which can affect BCR-free and func-
tional outcomes.Nowadays, all the laparoscopic prostatectomies in our
Department are performed with the auxilium of 3D
video system. If these preliminary data will be confirmed
by larger follow-up of a greater number of patients, the
4th generation 3D laparoscopy may play an important
role in the treatment of prostate cancer.
Conclusions
This preliminary study has shown that 4th generation
3D-HD vision system provides advantages over standard
bi-dimensional view with regard to intraoperative steps.
Our data suggest a trend of improvement in intraopera-
tive blood loss and early postoperative recovery of con-
tinence along with the respect of the oncological safety.
Pentafecta has been reached with a higher score for the
3D-HD LERP.
Given the large number of men diagnosed with pros-
tate cancer and the exponential growth of the medical
costs on a global level, it would be better that treatment
options are not only effective but also less expensive. In
this context, the 3D laparoscopy may be an intermediate
step between the standard 2D laparoscopy and robot-
assisted laparoscopy, allowing the combination of the
low cost of the first with the 3D technology of the sec-
ond. Further studies are necessary to better comprehend
the role of 3D-LERP in modern urology.
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